Skip to content
healthcare.dev

Hydromorphone Hydrochloride

NDC 13811-701, Hydromorphone Hydrochloride, tablet, extended release, from Trigen Laboratories, LLC.

Product NDC
13811-701
Status
Listed
Labeler
Trigen Laboratories, LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205629
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13811-701 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROMORPHONE HYDROCHLORIDE8 mg/1

Pharmacologic classes

Full Opioid Agonists [MoA]; Opioid Agonist [EPC]

Package NDCNDC-11Package
13811-701-1013811070110100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-701-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8bb81796-6990-40e9-bee4-1f292f91ae99
  • NADAC price for package 13811070110

    GET /v1/drugs/nadac/13811070110

Use it

Look up 13811-701 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13811-701 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13811-701. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.